Humana reported 2025 revenue of $129.66 billion and Q1 2026 revenue of $39.65 billion. The thesis turns on whether Medicare Advantage scale can translate into durable margins and cash flow while medical cost trends, rate pressure and regulatory scrutiny remain central risks.
The valuation workbench is hidden from non-admin users until market-data licensing and trust disclosures are production-ready.
